Structures by: Jindal D. P.
Total: 29
17a-Allyl-17a-aza-D-homoandrost-4-en-3-one
C22H33NO
Acta Crystallographica Section E (2002) 58, 12 o1361-o1362
a=7.358(2)Å b=12.635(2)Å c=20.596(10)Å
α=90.00° β=90.00° γ=90.00°
16-(3-Pyridylmethylene) androst-4-ene-3,17-dione
C25H29NO2
Acta Crystallographica Section E (2002) 58, 12 o1359-o1360
a=11.4545(12)Å b=12.207(2)Å c=14.784(3)Å
α=90.00° β=90.00° γ=90.00°
N-(3-(2-isopropyl-5-methylphenoxy)-2-hydroxypropyl-N-(tert-butyl)ammonium oxalate
C17H30NO21,C2HO41
Acta Crystallographica Section E (2002) 58, 2 o93-o94
a=12.908(2)Å b=10.7630(10)Å c=15.784(2)Å
α=90.00° β=110.648(11)° γ=90.00°
16-(2-Pyridylmethylene)-androst-4-ene-3,17-dione
C25H29NO2
Acta Crystallographica Section E (2002) 58, 7 o753-o755
a=6.9910(10)Å b=11.674(2)Å c=13.528(2)Å
α=79.327(10)° β=76.866(13)° γ=78.438(14)°
2-(1H-indol-3-ylmethylene)indane-1-one
C18H13NO
Acta Crystallographica Section E (2002) 58, 11 o1222-o1223
a=12.3964(17)Å b=4.961(4)Å c=21.330(4)Å
α=90.00° β=90.00° γ=90.00°
3β,17β-Diacetoxy-16-(3-pyridylmethylene)androst-5-ene monohydrate
C29H37NO4,H2O
Acta Crystallographica Section E (2002) 58, 11 o1224-o1226
a=11.523(2)Å b=15.279(4)Å c=15.409(6)Å
α=90.00° β=90.00° γ=90.00°
2-[(2-Oxopyrrolidin-1-yl)carbonylmethyl]-2,3-dihydro-1H-isoindole-1,3-dione
C14H12N2O4
Acta Crystallographica Section E (2003) 59, 7 o1012-o1013
a=10.7480(2)Å b=8.32800(10)Å c=27.9084(4)Å
α=90.00° β=90.00° γ=90.00°
N-(2-naphthyloxymethylcarbonyl)pyrrolidine
C16H17NO2
Acta Crystallographica Section E (2003) 59, 9 o1334-o1335
a=10.6427(2)Å b=8.8035(2)Å c=14.4306(2)Å
α=90.00° β=110.9738(11)° γ=90.00°
N,N-dimethyl-2-(2-naphthyloxy)acetamide monohydrate
C14H15NO2,H2O
Acta Crystallographica Section E (2003) 59, 8 o1120-o1122
a=51.8464(6)Å b=5.91340(10)Å c=8.31120(10)Å
α=90.00° β=97.4569(5)° γ=90.00°
17a-Allyl-3β-pyrrolidino-17a-aza-D-homoandrost-5-ene monohydrate
C26H42N2,H2O
Acta Crystallographica Section E (2004) 60, 5 o745-o746
a=6.999(5)Å b=11.569(5)Å c=29.441(10)Å
α=90.00° β=90.00° γ=90.00°
16-[4-(3-chloropropoxy)-3-methoxybenzylidene]-17-oxoandrost-5-en-3β-ol
C30H39ClO4
Acta Crystallographica Section C (2004) 60, 1 o75-o78
a=34.3749(8)Å b=34.3749(8)Å c=5.75850(10)Å
α=90° β=90° γ=120°
16-Cyano-3α-(5-methyl-1,3,4-oxadiazol-2-yl)-13,16-seco-17-norandrost- 5-en-3β-yl acetate
C23H31N3O3
Acta Crystallographica Section C (2004) 60, 2 o161-o162
a=6.18550(10)Å b=7.55110(10)Å c=22.6406(4)Å
α=90° β=95.9439(10)° γ=90°
2'-(p-fluorophenyl)-17a-aza-2'H-pyrazolo[4',3':16,17]-D-homoandrost-4-en-3-one
C26H30FN3O
Acta Crystallographica Section C (2004) 60, 2 o158-o160
a=13.5243(2)Å b=7.39830(10)Å c=21.8934(3)Å
α=90° β=102.1562(8)° γ=90°
16-[3-methoxy-4-(2-pyrrolidin-1-ylethoxy)benzylidene]- 3β-pyrrolidinoandrost-5-en-17β-ol monohydrate
C37H54N2O3,H2O
Acta Crystallographica Section C (2004) 60, 1 o75-o78
a=6.42190(10)Å b=32.4115(5)Å c=8.09810(10)Å
α=90° β=99.6510(7)° γ=90°
16-(4-isopropylbenzylidene)androst-4-ene-3,17-dione
C29H36O2
Acta Crystallographica Section C (2004) 60, 2 o110-o112
a=6.1318(2)Å b=17.3938(5)Å c=22.3210(7)Å
α=90.00° β=90.00° γ=90.00°
4-(2-Naphthyloxymethylcarbonyl)morpholine
C16H17NO3
Acta Crystallographica Section C (2003) 59, 8 o467-o469
a=10.5594(2)Å b=9.2956(2)Å c=14.1012(3)Å
α=90.00° β=109.0917(9)° γ=90.00°
N-(2-naphthyloxymethylcarbonyl)piperidine
C17H19NO2
Acta Crystallographica Section C (2003) 59, 8 o422-o425
a=9.87690(10)Å b=24.8789(3)Å c=5.73350(10)Å
α=90.00° β=90.00° γ=90.00°
1-(2-Naphthyloxymethylcarbonyl)-4-methylpiperazine
C17H20N2O2
Acta Crystallographica Section C (2003) 59, 8 o467-o469
a=13.7560(3)Å b=12.7389(2)Å c=8.5031(2)Å
α=90.00° β=90.00° γ=90.00°
1-[2-(4-Nitrophenoxy)acetyl]pyrrolidin-2-one
C12H12N2O5
Acta Crystallographica Section C (2003) 59, 9 o514-o515
a=5.28130(10)Å b=8.7367(2)Å c=12.9843(3)Å
α=80.4656(14)° β=81.4302(12)° γ=83.8830(10)°
3-Methyl-N-(2-naphthyloxymethylcarbonyl)piperidine
C18H21NO2
Acta Crystallographica Section C (2003) 59, 8 o422-o425
a=20.9438(4)Å b=20.9438(4)Å c=13.9169(2)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Fluorophenyl)-[1,2,3]triazolo[4',5':16,17]androst-5-en-3β-ol methanol hemisolvate
C25H30FN3O,0.5CH4O
Acta Crystallographica Section C (2004) 60, 6 o405-o407
a=6.80860(10)Å b=10.5682(3)Å c=32.5223(7)Å
α=80.7761(9)° β=87.7492(13)° γ=74.1122(11)°
4-(3,17-Dioxoandrost-4-en-16-ylidenemethyl)benzonitrile
C27H29NO2
Acta Crystallographica Section C (2002) 58, 3 o162-o163
a=7.7638(10)Å b=8.4584(10)Å c=33.220(5)Å
α=90° β=90° γ=90°
16-(4-Cyanobenzylidene)-3β-pyrrolidinoandrost-5-en-17β-ol monohydrate
C31H40N2O,H2O
Acta Crystallographica Section C (2002) 58, 7 o421-o422
a=7.2171(6)Å b=18.541(3)Å c=20.176(6)Å
α=90° β=90° γ=90°
3β-(1-Allyl-1-pyrrolidinio)-16-(2-pyridylmethylene)androst-5-ene-17β-ol bromide hemihydrate
C32H45BrN2O,0.5H2O
Acta Crystallographica Section C (2002) 58, 10 o598-o599
a=21.054(4)Å b=9.3083(18)Å c=15.551(4)Å
α=90° β=106.15(2)° γ=90°
Synthetic steroid
C36H49NO5,H2O
Acta Crystallographica Section C (2002) 58, 12 o727-o729
a=6.17260(10)Å b=14.9068(2)Å c=17.6465(3)Å
α=90.00° β=97.7240(10)° γ=90.00°
16-(4-Cyanobenzylidene)-17-oxoandrost-5-en-3β-ol
C27H31NO2
Acta Crystallographica Section C (2003) 59, 4 o213-o215
a=6.005(3)Å b=17.448(4)Å c=10.453(5)Å
α=90.00° β=93.846(4)° γ=90.00°
17-Oxo-16-(2-pyridylmethylene)-androst-5-en-3β-ol monohydrate
C25H31NO2,H2O
Acta Crystallographica Section C (2001) 57, 9 1062-1063
a=6.5376(3)Å b=11.8766(10)Å c=13.5312(15)Å
α=90.00° β=91.197(12)° γ=90.00°
2-(p-fluorophenyl)-4-aza-pyrazolo[4',3':2,3]-5α-androstan-17β-yl acetate
C27H34FN3O2
Acta Crystallographica Section C (2003) 59, 12 o724-o726
a=7.25450(10)Å b=13.5417(2)Å c=23.6387(4)Å
α=90.00° β=90.00° γ=90.00°
2-(p-fluorophenyl)-4-aza-pyrazolo[4',3':2,3]-5α-androstan-17β-ol
C25H32FN3O
Acta Crystallographica Section C (2003) 59, 12 o724-o726
a=7.0990(2)Å b=14.8153(4)Å c=20.2961(4)Å
α=90.00° β=90.00° γ=90.00°